Literature DB >> 9168063

Curcumin, a compound with anti-inflammatory and anti-oxidant properties, down-regulates chemokine expression in bone marrow stromal cells.

Y X Xu1, K R Pindolia, N Janakiraman, C J Noth, R A Chapman, S C Gautam.   

Abstract

Chemotactic cytokines or chemokines play an important role in the regulation of myelopoiesis. Since the production of chemokines and colony stimulating factors (CSFs) by bone marrow stromal cells requires inflammatory conditions, we investigated the effect of curcumin, an agent with anti-inflammatory and anti-oxidant activities, on the expression of monocyte chemoattractant protein-1 (MCP-1 or MCP-1/JE) and interferon inducible protein-10kD (IP-10) in mouse bone marrow stromal cell line +/+-1.LDA11. Both chemokines are readily expressed in stromal cells after stimulation with pro-inflammatory interleukin-1alpha (IL-1alpha), interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha), and endotoxin lipopolysaccharide (LPS). Curcumin attenuates the levels of MCP-1/JE and IP-10 mRNA expression by all of these stimulatory agents. A detailed analysis of the regulatory effects of curcumin on chemokine expression by IL-1alpha was performed. Curcumin inhibits both chemokine mRNAs in a dose- and time-dependent manner. The suppressive effect of curcumin on both mRNAs is reversible with complete recovery from suppression within 24 hours after removal of curcumin. The suppression of mRNA by curcumin is dependent on de novo synthesis of an intermediary protein(s), since suppression is abrogated by concomitant treatment with cycloheximide (CHX). Destabilization of mRNA transcripts is not the mechanism by which curcumin lowers the levels of mRNA; however, transcripts formed in the presence of curcumin are more stable, as indicated by their slower degradation kinetics. Run-on transcriptional assays demonstrate that curcumin inhibits the transcriptional activity of both genes. Finally, the attenuation of chemokine gene expression is associated with decreased production of chemotactic activity. Together, these findings indicate that while curcumin may post-transcriptionally stabilize mRNA transcripts formed in its presence, the overall reduction in mRNA levels by curcumin is mediated by inhibition of the transcription of chemokine genes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9168063

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  26 in total

1.  Curcuminoids activate p38 MAP kinases and promote UVB-dependent signalling in keratinocytes.

Authors:  Elias E Ayli; Susanne Dugas-Breit; Weijie Li; Christine Marshall; Liang Zhao; Marc Meulener; Thomas Griffin; Joel M Gelfand; John T Seykora
Journal:  Exp Dermatol       Date:  2010-04-20       Impact factor: 3.960

Review 2.  Cancer cell signaling pathways targeted by spice-derived nutraceuticals.

Authors:  Bokyung Sung; Sahdeo Prasad; Vivek R Yadav; Bharat B Aggarwal
Journal:  Nutr Cancer       Date:  2011-12-09       Impact factor: 2.900

3.  Curcumin suppresses T cell activation by blocking Ca2+ mobilization and nuclear factor of activated T cells (NFAT) activation.

Authors:  Christian Kliem; Anette Merling; Marco Giaisi; Rebecca Köhler; Peter H Krammer; Min Li-Weber
Journal:  J Biol Chem       Date:  2012-02-02       Impact factor: 5.157

4.  Enhancement of phototoxicity of curcumin in human oral cancer cells using silica nanoparticles as delivery vehicle.

Authors:  Surya Prakash Singh; Mrinalini Sharma; Pradeep Kumar Gupta
Journal:  Lasers Med Sci       Date:  2013-06-27       Impact factor: 3.161

5.  Synthesis of novel 4-Boc-piperidone chalcones and evaluation of their cytotoxic activity against highly-metastatic cancer cells.

Authors:  Carlimar Ocasio-Malavé; Metsiel J Donate; María M Sánchez; Jesús M Sosa-Rivera; Joseph W Mooney; Tomás A Pereles-De León; Néstor M Carballeira; Beatriz Zayas; Christian E Vélez-Gerena; Magaly Martínez-Ferrer; David J Sanabria-Ríos
Journal:  Bioorg Med Chem Lett       Date:  2019-10-28       Impact factor: 2.823

Review 6.  "Spicing up" of the immune system by curcumin.

Authors:  Ganesh Chandra Jagetia; Bharat B Aggarwal
Journal:  J Clin Immunol       Date:  2007-01-09       Impact factor: 8.317

Review 7.  Nanomedicine and advanced technologies for burns: Preventing infection and facilitating wound healing.

Authors:  Mirza Ali Mofazzal Jahromi; Parham Sahandi Zangabad; Seyed Masoud Moosavi Basri; Keyvan Sahandi Zangabad; Ameneh Ghamarypour; Amir R Aref; Mahdi Karimi; Michael R Hamblin
Journal:  Adv Drug Deliv Rev       Date:  2017-08-04       Impact factor: 15.470

Review 8.  Perspectives on chemopreventive and therapeutic potential of curcumin analogs in medicinal chemistry.

Authors:  Subhash Padhye; Deepak Chavan; Shubhangini Pandey; Jyoti Deshpande; K Venkateswara Swamy; Fazlul H Sarkar
Journal:  Mini Rev Med Chem       Date:  2010-05       Impact factor: 3.862

9.  The effect of curcumin on the brain-gut axis in rat model of irritable bowel syndrome: involvement of 5-HT-dependent signaling.

Authors:  Yingcong Yu; Shujuan Wu; Jianxin Li; Renye Wang; Xupei Xie; Xuefeng Yu; Jianchun Pan; Ying Xu; Liang Zheng
Journal:  Metab Brain Dis       Date:  2014-05-08       Impact factor: 3.584

10.  New difluoro Knoevenagel condensates of curcumin, their Schiff bases and copper complexes as proteasome inhibitors and apoptosis inducers in cancer cells.

Authors:  Subhash Padhye; Huanjie Yang; Abeda Jamadar; Qiuzhi Cindy Cui; Deepak Chavan; Kristin Dominiak; Jaclyn McKinney; Sanjeev Banerjee; Q Ping Dou; Fazlul H Sarkar
Journal:  Pharm Res       Date:  2009-05-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.